News
Experimental cancer vaccine passes animal tests, moves to human trials
November 29, 2020 /
A novel cancer vaccine is moving to Phase 1 human trials in the United States after promising results from animal studies showed encouraging efficacy and a robust safety profile. A new study describes the vaccine as producing complete responses in 90 percent of animals when combined with a second immunotherapy drug.
MATR Supporters (view all)
Posted in: Incubators and R&D
Sorry, we couldn't find any posts. Please try a different search.